Mitochondrial Electron Transport and ATP Synthesis

Mitochondrial Structure and Origins

  • Endosymbiosis Theory: Mitochondria originated from a symbiotic relationship between host cells and prokaryotes.

  • Membrane Specialized Structure:   - Outer Membrane: Freely permeable to small molecules.   - Inner Membrane: Highly impermeable, requiring specific carriers; folded into cristae to increase surface area for electron transport chain (ETC) proteins.

  • Function: The mitochondrion catalyzes the conversion of energy from NADH oxidation to the phosphorylation of ADP, forming ATP via oxidative phosphorylation.

Overview of the Electron Transport Chain (ETC)

  • Objective: Transfer electrons from NADH and FADH₂ to the final electron acceptor, oxygen (O2O_2), to form water (H2OH_2O).

  • Net Reaction: NADH+1/2O2+H+NAD++H2ONADH + 1/2 O_2 + H^+ \rightarrow NAD^+ + H_2O.

  • Stepwise Release: Energy is released gradually through four complexes to prevent explosive energy loss as heat, allowing for efficient harness into a proton gradient.

  • Mobile Carriers:   - Coenzyme Q (Ubiquinone): A small, lipid-soluble benzoquinone that carries electrons between Complex I/II and Complex III within the lipid bilayer.   - Cytochrome c: A water-soluble protein on the outer surface of the inner membrane that transfers electrons from Complex III to Complex IV using electrostatic interactions via Lysine residues.

ETC Complexes and Proton Pumping

  • Complex I (NADH Dehydrogenase / NADH-Coenzyme Q Reductase):   - Contains at least 4646 proteins, FMN, and Fe-S clusters.   - Transfers electrons from NADH to Coenzyme Q.   - Action: Pumps 4H+4\,H^+ from the matrix to the intermembrane space.

  • Complex II (Succinate Dehydrogenase / Succinate-Coenzyme Q Reductase):   - Part of the TCA cycle; converts succinate to fumarate.   - Transfers electrons from FADH₂ to Coenzyme Q via Fe-S centers.   - Action: Does NOT pump protons.

  • Complex III (Cytochrome c Reductase / Coenzyme Q - Cytochrome c Reductase):   - Composed of cytochrome b, cytochrome c1, and the Fe-S Rieske protein.   - Action: Pumps 4H+4\,H^+ and transfers electrons to Cytochrome c.

  • Complex IV (Cytochrome c Oxidase):   - Contains cytochrome a, cytochrome a3, and two Cu complexes.   - Reduces O2O_2 to 2H2O2\,H_2O (O2+4H++4e2H2OO_2 + 4H^+ + 4e^- \rightarrow 2\,H_2O).   - Action: Pumps 2H+2\,H^+ across the membrane.

ATP Synthesis (Complex V)

  • Structure:   - F1F_1 Catalytic Subunit: Located in the matrix; stoichiometry α3β3γδϵ\alpha_3\beta_3\gamma\delta\epsilon.   - FoF_o Complex: Integral membrane proteins mediating proton transport.

  • Mechanism: Driven by the proton-motive force (an electrochemical gradient consisting of both concentration and electrical potential components).

  • Binding Change Mechanism (Paul Boyer):   - Proton flow through FoF_o causes rotation of the shaft relative to the β\beta subunits.   - Three Conformations: Loose (binds ADP + Pi), Tight (forms ATP), and Open (releases ATP).

  • Requirement: Approximately 3H+3\,H^+ are required to synthesize one molecule of ATP.

Metabolic Regulation and Uncoupling

  • Respiratory Control: Respiration is dependent on the availability of ADP; without ADP, protons cannot flow back, stopping the ETC.

  • Uncouplers (e.g., 2,4-dinitrophenol): Lipid-soluble weak acids that dissipate the proton gradient by carrying H+H^+ back into the matrix. They allow respiration to continue without ATP synthesis, releasing energy as heat.

  • Thermogenin (Uncoupling Protein): Found in brown adipose tissue; used by newborns and hibernating mammals for non-shivering thermogenesis.

  • Inhibitors:   - Statins: Inhibit Coenzyme Q10 synthesis because it shares the same precursor (mevalonate) as cholesterol.   - Cyanide: Blocks electron transfer in Complex IV.

Clinical Relevance and Mitochondrial Disease

  • Complex I Deficiency: The most frequent cause of oxidative phosphorylation disorders.

  • Symptoms: Includes progressive encephalomyopathies, cardiomyopathy, and metabolic acidosis.

  • Genetics: Mitochondrial diseases are often maternally transmitted. The severity of the disease in offspring depends on the Bottleneck Effect, where the number of mutant mitochondria in the mature egg varies randomly.

  • Prevalence: Estimated at 11 in 2,5002,500 to 4,0004,000 births.